- Novel Coronavirus
-
Drug Discovery Services
- Antiviral Drug Discovery
- Complement Therapy
- SARS-CoV-2 Aptamers
- Antisense Oligonucleotides
- Protease Inhibitors
- Inhibitor of Host Cell Protease
- Abelson Kinase Inhibitors
- RNA Synthesis Inhibitors
- Nucleoside Analogue
- Neuraminidase Inhibitors
- Neutralizing Antibody
- Antiviral Peptide
- Broad-spectrum Antiviral Drug
- Anti-Inflammatory Drugs
- High-Throughput Screening
- Vaccine Discovery
- Evaluation Platforms for SARS-CoV-2 Drugs
- Antiviral Drug Discovery
- IVD Immunoassays
- Products
- Resources
- About Us
[13C3]-Ritonavir (CAT#: Vinh-Wyb008)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| Vinh-Wyb008 |
|
For Research Use Only. We do not provide direct services or products for patients.
- Product Overview
- Molecular Formula: C37H42D6N6O5S2; Molecular Weight: 726.98 g.mol-1
- CAS No.
- 1217673-23-8
- Target
- SARS-CoV-2
- Molecular Formula
- C37H48N6O5S2
- Molecular Weight
- 723.97 g.mol-1
- Introduction
- Ritonavir is an effective inhibitor of CYP3A-mediated biotransformation, and is also an effective oral inhibitor of human immunodeficiency virus-1 (HIV-1) and human immunodeficiency virus-2 (HIV-2) aspartic proteases. Ritonavir can block the process by which this enzyme produces the polyproteins required for morphologically mature HIV particles, thereby keeping the HIV particles in an immature state, thereby slowing the spread of HIV in cells to prevent a new round Infection and delays the development of the disease.
Online Inquiry
For Research Use Only. We do not provide direct services or products for patients.
For Research Use Only. We do not provide direct services or products for patients.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.